Pharmaceuticals and Healthcare Report Q3 2010 Market Research and Analysis June Update by ReportsandReports

News provided by

Jun 23, 2010, 08:09 ET

DALLAS, June 23, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Pharmaceuticals and Healthcare Market Research Report June update in its store.

Bangladesh Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/bangladesh- pharmaceuticals-and-healthcare-report-q3-2010/)

Out of the 16 key markets surveyed in BMI's Pharmaceuticals & Healthcare Business Environment Ratings, Bangladesh moves up two places to occupy 14th position in the table. This improvement sees it now placing above Pakistan and Cambodia, th... June 2010 $ 530

Bulgaria Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/bulgaria- pharmaceuticals-and-healthcare-report-q3-2010/)

BMI considers Bulgaria to be among the less attractive pharmaceutical markets in Emerging Europe, a view largely enforced by poor market dynamics and prolonged economic difficulties. In BMI's Pharmaceuticals & Healthcare Business Environment Ratings for June 2010 $ 530

Kazakhstan Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/kazakhstan- pharmaceuticals-and-healthcare-report-q3-2010/)

BMI retains its robust five-year growth forecast for the Kazakhstan pharmaceutical market, with the US dollar value of the market rebounding on the back of a resurgent local currency in 2010. Our forecast sees a strong economy - driven by increasing oil June 2010 $ 530

Belgium Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/belgium-pharmaceuticals -and-healthcare-report-q3-2010/)

Having received a somewhat lower compound score in Q310, Belgium is now placed joint fifth in the Western Europe Pharmaceuticals & Healthcare Business Environment Ratings (BER) matrix, on a par with the UK and below Germany, Switzerland and new inclusio June 2010 $ 530

Moldova Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/moldova-pharmaceuticals -and-healthcare-report-q3-2010/)

Moldova's pharmaceutical market was valued at US$208mn in 2009, and BMI calculates that the market will post a compound annual growth rate (CAGR) of 4.95% between 2009 and 2014 in US dollar terms, increasing to 8.45% growth between 2009 and 2019. Moldov June 2010 $ 530

Portugal Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/portugal-pharmaceuticals -and-healthcare-report-q3-2010/)

Portugal's pharmaceutical sales reached a value of EUR3.62bn (US$5.10bn) in 2009. It is BMI's view that the slowdown in drug market growth in Portugal in recent years will continue in 2010, with drug sales expected to reach a value of EUR3.64bn (US$5.27 June 2010 $ 530

Qatar Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/qatar-pharmaceuticals- and-healthcare-report-q3-2010/)

The total pharmaceutical market in Qatar will rise from a value of US$233mn in 2009 to US$419mn by 2014, at a CAGR of 12.45%. The proportion of GDP accounted for by drug spending will be 0.26% by this time. Per-capita spending on medicines will be US$22 June 2010 $ 530

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/zimbabwe- pharmaceuticals-and-healthcare-report-q3-2010/)

Zimbabwe remains firmly at the bottom of BMI's Business Environment Ratings for Q310, which looks at 19 key regional markets, now including Ghana and Iraq. Although an improvement on last quart... June 2010 $ 530

Slovenia Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/slovenia- pharmaceuticals-and-healthcare-report-q3-2010/)

In BMI's Business Environment Ratings (BER) table for Q310, Slovenia is ranked 10th of the 20 markets assessed in the Emerging Europe region, down by one place in relation to the previous quarter. Globally, Slovenia is ranked 38th out of 82... May 2010 $ 530

Italy Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/italy-pharmaceuticals- and-healthcare-report-q3-2010/)

In BMI's latest Pharmaceuticals & Healthcare Business Environment Ratings (BER), Italy remains the least attractive Western European market of the ten surveyed. Despite being a large market, Italy is characterised by low levels of growth, l... May 2010 $ 530

Taiwan Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/taiwan-pharmaceuticals- and-healthcare-report-q3-2010/)

Taiwan's US$3.81bn pharmaceutical market is the sixth largest in Asia Pacific, well below Australia (US$8.61bn), but slightly ahead of Indonesia (US$3.66bn). Annual per-capita spending on medicines is US$165, just above the regional average... May 2010 $ 530

Jordan Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/jordan-pharmaceuticals- and-healthcare-report-q3-2010/)

The Jordan Association of Pharmaceutical Manufacturers states that the pharmaceutical sector in Jordan is export driven, which a glance at the trade balance confirms. There are 17 local pharmaceutical firms - the result of major consolidati... May 2010 $ 530

Algeria Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/algeria-pharmaceuticals- and-healthcare-report-q3-2010/)

BMI calculates the value of Algeria's pharmaceutical consumption to have been DZD169.55bn (US$2.36bn) in 2009. The market is characterised by a relatively low per-capita spend of US$68 and a large generics sector - 38% of total drug expendi... May 2010 $ 530

Germany Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/germany- pharmaceuticals-and-healthcare-report-q3-2010/)

Highlighting the effects of the impending patent cliff and the consequent consumption of lower-value generic drugs in place of high-value patented drugs, BMI calculates a decline in the growth of the German pharmaceutical market. BMI calcul... May 2010 $ 530

Iran Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/iran-pharmaceuticals- and-healthcare-report-q3-2010/)

In BMI's Middle East and Africa (MEA) Pharmaceutical Business Environment Ratings (BERs) for Q310, Iran is once again found in eighth place. Compared with its regional neighbours, Iran's score is buoyed by its growing population and healthc... May 2010 $ 530

South Korea Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/south-korea- pharmaceuticals-and-healthcare-report-q3-2010/)

In our latest Pharmaceutical and Healthcare Business Environment Ratings (BERs), South Korea can be found in pole position of the 16 markets surveyed in the Asia Pacific region, ahead of Japan and Australia. The upgrade is due to a re-evalu... May 2010 $ 530

Indonesia Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/indonesia- pharmaceuticals-and-healthcare-report-q3-2010/)

In the BMI Business Environment Rating matrix for Q310, we see Indonesia continue to occupy 12th position of the 16 regional markets surveyed in the Asia Pacific region. The country's pharmaceutical rating has risen to 47.2, marking a margi... May 2010 $ 530

Turkey Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/turkey-pharmaceuticals- and-healthcare-report-q3-2010/)

Turkey's pharmaceutical market remains one of the most attractive long-term prospects for pharmaceutical companies, despite negative regulatory changes over the past 12 months. In BMI's Business Environment Ratings for Q310, Turkey is fourt... May 2010 $ 530

Sweden Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/sweden-pharmaceuticals- and-healthcare-report-q3-2010/)

BMI considers Sweden one of the most attractive markets globally for pharmaceutical companies. Among the 82 countries in BMI's Global Business Environment Ratings, Sweden ranks fifth, behind the US, Germany, Canada and Switzerland. Des... May 2010 $ 530

Estonia Pharmaceuticals and Healthcare Report Q3 2010 (http://www.reportsandreports.com/market-reports/estonia- pharmaceuticals-and-healthcare-report-q3-2010/)

BMI views Estonia's pharmaceutical market as a mildly attractive proposition for multinational drugmakers. Estonia ranks 11th in BMI's Pharmaceuticals & Healthcare Business Environment Ratings for Emerging Europe in Q310 and places 43rd on ... May 2010 $ 530

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

    Contact:
    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    http://www.reportsandreports.com/
    http://reportsnreports.wordpress.com/